Clinical Trials
2 trialsNCT01100931 2015-10-19
A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II)
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT00328588 2008-01-02
LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy
Astellas Pharma Inc
Phase 2 Completed